Mivacurium in special patient groups
暂无分享,去创建一个
[1] T. Taivainen,et al. Recent developments in muscle relaxation in children , 1994 .
[2] T. Sharpe,et al. Neuromuscular and haemodynamic effects of mivacurium in elderly and young adult patients. , 1994, British journal of anaesthesia.
[3] T. Taivainen,et al. Pharmacodynamics of mivacurium in infants. , 1994, British journal of anaesthesia.
[4] A. Al-Ghamdi,et al. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block. , 1993, British journal of anaesthesia.
[5] J. Hunter,et al. Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis. , 1993, British journal of anaesthesia.
[6] T. Taivainen,et al. Accelerated onset and delayed recovery of neuromuscular block induced by mivacurium preceded by pancuronium in children. , 1993, Anesthesia and analgesia.
[7] R. Welch,et al. Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. , 1992, British journal of anaesthesia.
[8] R. Mirakhur,et al. Dose-response relationships for neostigmine antagonism of vecuronium-induced neuromuscular block in adults and the elderly. , 1992, British journal of anaesthesia.
[9] J. Hunter,et al. Use of mivacurium chloride by constant infusion in the anephric patient. , 1992, British journal of anaesthesia.
[10] J. Hunter. EDITORIAL I RESISTANCE TO NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS , 1991 .
[11] F. McGowan,et al. DOSE-RESPONSE RELATIONSHIP OF MIVACURIUM CHLORIDE (MIVACRON®) IN INFANTS DURING NITROUS OXIDE-HALOTHANE ANESTHESIA , 1991 .
[12] D. Goldhill,et al. Neuromuscular and clinical effects of mivacurium chloride in healthy adult patients during nitrous oxide-enflurane anaesthesia. , 1991, British journal of anaesthesia.
[13] J. Hunter. Resistance to non-depolarizing neuromuscular blocking agents. , 1991, British journal of anaesthesia.
[14] O. Meretoja. Neuromuscular Blocking Agents in Paediatric Patients: Influence of Age on the Response , 1990, Anaesthesia and intensive care.
[15] D. R. Cook,et al. Mivacurium Infusion Requirements in Pediatric Surgical Patients During Nitrous Oxide‐Halothane and During Nitrous Oxide‐Narcotic Anesthesia , 1990, Anesthesia and analgesia.
[16] R. Miller,et al. Pharmacokinetics and pharmacodynamics of atracurium in infants and children. , 1990, Anesthesiology.
[17] C. Meistelman,et al. Recovery from vecuronium neuromuscular blockade following neostigmine administration in infants, children, and adults during halothane anesthesia. , 1989, Anesthesiology.
[18] J. Kirchner,et al. Neuromuscular and cardiovascular effects of mivacurium chloride in surgical patients receiving nitrous oxide-narcotic or nitrous oxide-isoflurane anaesthesia , 1989, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[19] T. Heier,et al. Comparison of the neuromuscular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia. , 1989, British journal of anaesthesia.
[20] B. Jonson,et al. Monitoring of physiological parameters during high frequency ventilation (HFV) , 1989, Acta anaesthesiologica Scandinavica. Supplementum.
[21] R. Welch,et al. In Vitro Metabolism of Mivacurium Chloride (BW B1090U) and Succinylcholine , 1989, Anesthesia and analgesia.
[22] N. Goudsouzian,et al. Neuromuscular and cardiovascular effects of mivacurium in children. , 1989, Anesthesiology.
[23] B. Brandom,et al. Clinical Pharmacology of Mivacurium Chloride (BW B1090U) in Children During Nitrous Oxide‐Halothane and Nitrous Oxide‐Narcotic Anesthesia , 1989, Anesthesia and analgesia.
[24] W. Wargin,et al. NEUROMUSCULAR EFFECTS AND PHARMACOKINETICS OF OOXACURIUM IN ELDERLY PATIENTS UNDER ISOFLURANE ANESTHESIA , 1988 .
[25] Ronald D. Miller,et al. The Pharmacodynamics and Pharmacokinetics of Vecuronium in Patients Anesthetized with Isoflurane with Normal Renal Function or with Renal Failure , 1988, Anesthesiology.
[26] H. H. Ali,et al. The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short‐acting Nondepolarizing Ester Neuromuscular Blocking Drug , 1988, Anesthesiology.
[27] G. Meakin,et al. Comparison of atracurium-induced neuromuscular blockade in neonates, infants and children. , 1988, British journal of anaesthesia.
[28] D. R. Cook,et al. Pharmacokinetics of atracurium in anaesthetized infants and children. , 1986, British journal of anaesthesia.
[29] C A Shanks,et al. Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens. , 1986, Anesthesiology.
[30] R. Miller,et al. Neuromuscular Effects of Atracurlum during Halothane—Nitrous Oxide and Enflurane—Nitrous Oxide Anesthesia in Humans , 1985, Anesthesiology.
[31] P. Duvaldestin,et al. Pharmacokinetics and Pharmacodynamics of Vecuronium (ORG NC 45) in Patients with Cirrhosis , 1985, Anesthesiology.
[32] P. Gencarelli,et al. Vecuronium Infusion Dose Requirements during Fentanyl and Halothane Anesthesia in Humans , 1985, Anesthesia and analgesia.
[33] Ronald D. Miller,et al. Vecuronium kinetics and dynamics in anesthetized infants and children , 1985, Clinical pharmacology and therapeutics.
[34] F. Donati,et al. CUMULATION OF VECURONIUM IN RENAL FAILURE , 1984 .
[35] Ronald D. Miller,et al. ATRACURIUM NEUROMUSCULAR BLOCKADE DURING HALOTHANE/N2O AND ENFLURANE/N2O ANESTHESIA IN HUMANS , 1984 .
[36] R. Matteo,et al. Distribution, Elimination, and Action of d‐Tubocurarine in Neonates, Infants, Children, and Adults , 1984, Anesthesia and analgesia.
[37] R. Miller,et al. Vecuronium‐induced Neuromuscular Blockade during Enflurane, Isoflurane, and Halothane Anesthesia in Humans , 1984, Anesthesiology.
[38] D. Bevan,et al. Neostigmine and Edrophonium as Antagonists of Pancuronium in Infants and Children , 1983, Anesthesiology.
[39] L. Barvais,et al. Clinical evaluation of atracurium besylate requirement for a stable muscle relaxation during surgery: lack of age-related effects. , 1983, Anesthesiology.
[40] D. Moyes,et al. EFFECTS OF LOW INTERMITTENT CONCENTRATIONS OF NITROUS OXIDE ON THE DEVELOPING RAT FETUS , 1983 .
[41] R. Miller,et al. Neuromuscular and cardiovascular effects of atracurium during nitrous oxide-fentanyl and nitrous oxide-isoflurane anaesthesia. , 1983, British journal of anaesthesia.
[42] J. Hunter,et al. Use of atracurium in patients with no renal function. , 1982, British journal of anaesthesia.
[43] H. S. Chadwick. RELATIVE LIDOCAINE AND BUPIVACAINE TOXICITY IN VENTILATED CATS , 1982 .
[44] D. Stanski,et al. Pharmacokinetics and Pharmacodynamics of d‐Tubocurarine in Infants, Children, and Adults , 1982, Anesthesiology.
[45] P. Duvaldestin,et al. Binding of tubocurarine, fazadinium, pancuronium and Org NC 45 to serum proteins in normal man and in patients with cirrhosis. , 1982, British journal of anaesthesia.
[46] D. Stanski,et al. Pharmacokinetics of edrophonium in anephric and renal transplant patients. , 1981, British journal of anaesthesia.
[47] R. Marsh,et al. Recovery from pancuronium , 1980, Anaesthesia.
[48] L. Sheiner,et al. Pyridostigmine kinetics with and without renal function , 1980, Clinical pharmacology and therapeutics.
[49] N. Goudsouzian. Maturation of neuromuscular transmission in the infant. , 1980, British journal of anaesthesia.
[50] D. Newton,et al. Influence of halothane and enflurane on the neuromuscular effects of ORG NC 45 in man. , 1980, British Journal of Anaesthesia.
[51] L. Sheiner,et al. Renal function and the pharmacokinetics of neostigmine in anesthetized man. , 1979 .
[52] D. Cullen,et al. Renal failure and postoperative respiratory failure: recurarization? , 1976, British journal of anaesthesia.
[53] L. Strunin,et al. Althesin and pancuronium in chronic liver disease. , 1975, British journal of anaesthesia.
[54] D. R. Cook,et al. Neuromuscular Blocking Effects of Succinylcholine in Infants and Children , 1975, Anesthesiology.
[55] M. Ghoneim,et al. Binding of d‐Tubocurarine to Plasina Proteins in Normal Man and in Patients with Hepatic or Renal Disease , 1973, Anesthesiology.
[56] B. Friis‐Hansen. Body composition during growth. In vivo measurements and biochemical data correlated to differential anatomical growth. , 1971, Pediatrics.
[57] J. Dundee,et al. Resistance to d-tubocurarine chloride in the presence of liver damage. , 1953, Lancet.